Your browser doesn't support javascript.
loading
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.
Kim, Bohyun; Jung, Minsun; Moon, Kyung Chul; Han, Dohyun; Kim, Kwangsoo; Kim, Hyeyoon; Yang, Sunah; Lee, Dongjoo; Jun, Hyeji; Lee, Kyung-Min; Lee, Cheng Hyun; Nikas, Ilias P; Yang, Sohyeon; Lee, Hyebin; Ryu, Han Suk.
Affiliation
  • Kim B; Department of Pathology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Jung M; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Moon KC; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Han D; Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim K; Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim H; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Yang S; Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee D; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Jun H; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee KM; Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee CH; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Nikas IP; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea.
  • Yang S; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee H; Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Ryu HS; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Int J Cancer ; 152(2): 320-330, 2023 01 15.
Article in En | MEDLINE | ID: mdl-36054443
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Language: En Journal: Int J Cancer Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Language: En Journal: Int J Cancer Year: 2023 Document type: Article